NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Thyrocare Technologies Limited (NSE: THYROCARE)
THYROCARE Technical Analysis
3
As on 3rd May 2024 THYROCARE SHARE Price closed @ 631.05 and we RECOMMEND Buy for LONG-TERM with Stoploss of 580.28 & Buy for SHORT-TERM with Stoploss of 629.63 we also expect STOCK to react on Following IMPORTANT LEVELS. |
THYROCARESHARE Price
Open | 644.15 | Change | Price | % |
High | 645.80 | 1 Day | -13.10 | -2.03 |
Low | 615.00 | 1 Week | -23.95 | -3.66 |
Close | 631.05 | 1 Month | 15.35 | 2.49 |
Volume | 48167 | 1 Year | 177.25 | 39.06 |
52 Week High 890.45 | 52 Week Low 419.90 |
NSE INDIA Most Active Stocks
YESBANK | 24.95 | -1.96% |
IDEA | 13.20 | 0.00% |
BHEL | 305.00 | 4.20% |
NHPC | 99.25 | 1.28% |
GTLINFRA | 1.75 | 0.00% |
IFCI | 52.50 | 4.90% |
RTNPOWER | 9.50 | 3.83% |
SAIL | 167.95 | 1.51% |
TATASTEEL | 166.50 | -0.51% |
PNB | 135.80 | -1.63% |
NSE INDIA Top Gainers Stocks
RBL | 1021.40 | 20.00% |
RBL | 1021.40 | 20.00% |
PENINLAND | 58.60 | 19.96% |
TFL | 13.85 | 19.91% |
TFL | 13.85 | 19.91% |
ARROWGREEN | 555.90 | 14.70% |
TOKYOPLAST | 131.00 | 13.86% |
AVTNPL | 98.95 | 11.05% |
ORIENTHOT | 150.00 | 10.74% |
UNIVASTU | 210.05 | 9.52% |
NSE INDIA Top Losers Stocks
COFORGE | 4482.55 | -10.09% |
VOLTAMP | 9983.05 | -8.81% |
EIMCOELECO | 2127.60 | -8.07% |
BLISSGVS | 119.05 | -8.00% |
APTECHT | 239.15 | -7.56% |
ARVSMART | 673.10 | -7.38% |
GENESYS | 567.75 | -6.75% |
GODHA | 0.70 | -6.67% |
WILLAMAGOR | 37.15 | -6.66% |
SILLYMONKS | 17.50 | -6.17% |
THYROCARE Daily Charts |
THYROCARE Intraday Charts |
Whats New @ Bazaartrend |
THYROCARE Free Analysis |
|
THYROCARE Important Levels Intraday
RESISTANCE | 690.40 |
RESISTANCE | 671.37 |
RESISTANCE | 659.60 |
RESISTANCE | 647.84 |
SUPPORT | 614.26 |
SUPPORT | 602.50 |
SUPPORT | 590.73 |
SUPPORT | 571.70 |
THYROCARE Target May 2024
4th UP Target | 899.42 |
3rd UP Target | 805.64 |
2nd UP Target | 747.67 |
1st UP Target | 689.7 |
1st DOWN Target | 524.3 |
2nd DOWN Target | 466.33 |
3rd DOWN Target | 408.36 |
4th DOWN Target | 314.58 |
THYROCARE Weekly Target
4th UP Target | 805.88 |
3rd UP Target | 757.49 |
2nd UP Target | 727.58 |
1st UP Target | 697.67 |
1st DOWN Target | 612.33 |
2nd DOWN Target | 582.42 |
3rd DOWN Target | 552.51 |
4th DOWN Target | 504.12 |
THYROCARE Target2024
4th UP Target | 1323.49 |
3rd UP Target | 1105.43 |
2nd UP Target | 970.64 |
1st UP Target | 835.85 |
1st DOWN Target | 451.25 |
2nd DOWN Target | 316.46 |
3rd DOWN Target | 181.67 |
4th DOWN Target | -36.39 |
Thyrocare Technologies Limited ( NSE INDIA Symbol : THYROCARE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
THYROCARE Synopsis Technicals View
50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is 37.28 | Sideways | |
MFI (14) | MFI is 47.28 | Sideways | |
CCI (20) | CCI is -72.69 | Sideways | |
WILLIAM %R (14) | William %R is -57.72 | Sideways | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Long Buy | 412.91 | |
10 Day Avg Volume | Traded 177.25 % More then 10 Day Average Volume |
THYROCARE Other Details
Segment | EQ | |
Market Capital | 60574277632.00 | |
Sector | Healthcare | |
Industry | Diagnostics & Research | |
Offical website | > echo $website ; ?> |
THYROCARE Address
THYROCARE Latest News
THYROCARE Business Profile
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through Diagnostic Testing Services, Imaging Services, and Others segments. The company conducts medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radio pharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. As of September 1, 2021, Thyrocare Technologies Limited operates as a subsidiary of Docon Technologies Private Limited. Address: D/37-3, TTC Industrial Area, Navi Mumbai, India, 400703
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service